Pharnext Announces Encouraging Data from Open ‐ Label Phase 3 Extension Study of PXT3003
Pharnext Announces Encouraging Data from Open ‐ Label Phase 3 Extension Study of PXT3003
Pharnext Announces Encouraging Data from Open ‐ Label Phase 3 Extension Study of PXT3003
Last Updated: Wednesday 8th January, 2020